The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
The expanding therapeutic armamentarium available for inflammatory bowel disease (IBD)
as well as multiple compounds in clinical development inevitably raises questions as to their …
as well as multiple compounds in clinical development inevitably raises questions as to their …
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - Gut, 2022 - search.proquest.com
The expanding therapeutic armamentarium available for inflammatory bowel disease (IBD)
as well as multiple compounds in clinical development inevitably raises questions as to their …
as well as multiple compounds in clinical development inevitably raises questions as to their …
[引用][C] The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment).
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - Gut, 2022 - europepmc.org
The future of drug development for inflammatory bowel disease: the need to ACT (advanced
combination treatment). - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
combination treatment). - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[引用][C] The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - Gut, 2022 - hal.science
The future of drug development for inflammatory bowel disease: the need to ACT (advanced
combination treatment) - Archive ouverte HAL Accéder directement au contenu Documentation …
combination treatment) - Archive ouverte HAL Accéder directement au contenu Documentation …
[引用][C] The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - Gut, 2022 - pubmed.ncbi.nlm.nih.gov
The future of drug development for inflammatory bowel disease: the need to ACT (advanced
combination treatment) The future of drug development for inflammatory bowel disease: the …
combination treatment) The future of drug development for inflammatory bowel disease: the …
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - Gut, 2022 - gut.bmj.com
The expanding therapeutic armamentarium available for inflammatory bowel disease (IBD)
as well as multiple compounds in clinical development inevitably raises questions as to their …
as well as multiple compounds in clinical development inevitably raises questions as to their …
[PDF][PDF] The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - researchgate.net
The expanding therapeutic armamentarium available for inflammatory bowel disease (IBD)
as well as multiple compounds in clinical development inevitably raises questions as to their …
as well as multiple compounds in clinical development inevitably raises questions as to their …
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
S Danese, V Solitano, V Jairath, L Peyrin-Biroulet - Gut, 2022 - search.proquest.com
The expanding therapeutic armamentarium available for inflammatory bowel disease (IBD)
as well as multiple compounds in clinical development inevitably raises questions as to their …
as well as multiple compounds in clinical development inevitably raises questions as to their …